# Study of LAU-7b for the Treatment of Long COVID in Adults

> **NCT05999435** · PHASE2,PHASE3 · COMPLETED · sponsor: **Laurent Pharmaceuticals Inc.** · enrollment: 272 (actual)

## Conditions studied

- Long COVID

## Interventions

- **DRUG:** LAU-7b for 3 cycles
- **DRUG:** LAU-7b for 1 cycle, then placebo
- **OTHER:** Placebo for 3 cycles

## Key facts

- **NCT ID:** NCT05999435
- **Lead sponsor:** Laurent Pharmaceuticals Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-15
- **Primary completion:** 2024-08-05
- **Final completion:** 2024-11-30
- **Target enrollment:** 272 (ACTUAL)
- **Last updated:** 2026-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05999435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05999435, "Study of LAU-7b for the Treatment of Long COVID in Adults". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05999435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*